Tuesday, December 8, 2020: Neuberg Diagnostics, India’s fourth largest diagnostics chain, today announced the appointment of Mr. A Ganesan as the Group Vice Chairman of Neuberg Diagnostics. In his new role, Mr. Ganesan will continue to play a key role and be actively involved in the business expansions.
Mr. Ganesan is a Chartered Accountant with over 33 years experience in Assurance and Advisory practice and also a veteran in healthcare field having handled in the past M&A deals for Metropolis group , Trivitron group and Maxivision Eye Hospitals At Neuberg, in his previous role as Director of Finance, his broad vision and pro-active efforts have enabled the company to win several accolades and making it one of the top 4 diagnostics companies in the country.
Dr. GSK Velu, Chairman and MD, Neuberg Diagnostics said, “Ganesan brings strong domain knowledge with breadth of business experience which currently is very critical for Neuberg. It has been 20 years since we have been working closely. Given his exceptional ability to drive businesses, we are sure that in this new role, he will enable the Group to step through our next phase of growth and market leadership.”
Mr. A Ganesan, Group Vice Chairman, Neuberg Diagnostics said, “I am honoured to lead our company which currently is in its expansion phase. I will endeavour to ensure we continue our journey on stated growth path. I look forward to working closely with distinguished leadership.”
Mr Ganesan is a Chemistry graduate from Madras University and a fellow member of The Institute of Chartered Accountants of India (ICAI). He is presently on the Board of Trivitron Healthcare Private Ltd, Kauvery Hospital and Maxivision Eye Hospitals Private Ltd. He was also a Director on the Board of Metropolis Healthcare Ltd., which he had relinquished in 2015.
About Neuberg Diagnostics:
Best-in-class laboratories across India, USA, UAE & South Africa have united under the banner of Neuberg Diagnostics, to bring the latest technology and techniques within the reach of developing countries. Utilizing their combined strengths, the Neuberg Alliance brings capabilities to perform over 6000 varieties of Pathological investigations and promotes Prevention & Early Diagnosis, Focused Wellness Programs and Structured Disease Management programs for rare diseases using the most advanced technologies assisted by Data science and AI tools.
Today, Neuberg Diagnostics is among the top diagnostics companies of Indian origin and the fastest growing healthcare start-up in India. The founding members of the Neuberg consortium - Anand Diagnostic Laboratory (Bangalore), SupratechMicropath (Ahmedabad), Ehrlich Laboratory (Chennai), Global Labs (South Africa), and Minerva Diagnostics (Dubai) bring their combined heritage of over 200 years, and process over 20 million tests annually. With 7 approved labs for Covid testing, the group has processed more than 1.5 million RT PCR Tests in India and South Africa. Some of the best Pathologists, Biochemists, Geneticists, Microbiologists and several other Clinical Lab Professionals from around the world are working closely, sharing knowledge and using the latest generation of diagnostics techniques to take accurate and timely diagnosis to the next level.
Apart from the coming together of leading players, green field laboratories have been established in Cochin, Trivandrum and Hyderabad. Currently the group has 70 labs and over 700 touch points across 4 countries. Our Indian Expansion plans include setting up a network of 500 collection centers across the country within the next 12 months. Our Overseas expansion plans include establishing a presence in East Africa, West Africa, Sri Lanka, Nepal, Bangladesh, USA and Germany.
Neuberg also provides Hospital Laboratory Management Services, Preventive Health Checks, Corporate Wellness, Home Health Services and Drive through Phlebotomy Services.